Edwards Lifeciences, LLC

Edwards Lifeciences, LLC has 1 AI-enabled medical device on the FDA list. The first decision was on May 21, 2019 and the most recent on May 21, 2019 (Acumen Hypotension Prediction Index – EV1000 Clinical Platform, Acumen Hypotension Prediction Index – HemoSphere Advanced Monitoring Platform, Acumen Hypotension Prediction Index – HemoSphere Advanced Monitoring Platform - Pressure). Its most common review panel is Cardiovascular (1 device).